| Mary M Monser, CRNA | |
|
112 N 7th St, Chambersburg, PA 17201-1720 | |
| (717) 267-7164 | |
| (717) 267-7414 |
| Full Name | Mary M Monser |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 112 N 7th St, Chambersburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477855369 | NPI | - | NPPES |
| 103904382 | Medicaid | PA | |
| 15190305 | Other | CAQH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN552452 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Pinnacle Hanover | Hanover, PA | Hospital |
| Chambersburg Hospital | Chambersburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
| Summit Physician Services | 5496659484 | 353 |
| North American Partners In Anesthesia, Pennsylvania , Llc | 7517960834 | 368 |
News Archive
Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to distribute its HearTwave II System and proprietary Microvolt T-Wave Alternans (MTWA) software and Micro-V Alternans Sensors in Singapore upon regulatory approval.
Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd have developed a new treatment for cancer which rather than attacking tumours directly, prevents the growth of new blood vessels in tumours, starving them of oxygen and nutrients, thereby preventing their growth.
There is currently no cure for liver cirrhosis and a patient's only hope of survival is to receive a liver transplant.
Children with serious skin conditions feel their quality of life is impaired to the same extent as those with chronic illnesses such as epilepsy, renal disease and diabetes, according to research published in the July issue of British Journal of Dermatology.
› Verified 4 days ago
| Entity Name | Summit Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306840814 PECOS PAC ID: 5496659484 Enrollment ID: O20031121000259 |
News Archive
Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to distribute its HearTwave II System and proprietary Microvolt T-Wave Alternans (MTWA) software and Micro-V Alternans Sensors in Singapore upon regulatory approval.
Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd have developed a new treatment for cancer which rather than attacking tumours directly, prevents the growth of new blood vessels in tumours, starving them of oxygen and nutrients, thereby preventing their growth.
There is currently no cure for liver cirrhosis and a patient's only hope of survival is to receive a liver transplant.
Children with serious skin conditions feel their quality of life is impaired to the same extent as those with chronic illnesses such as epilepsy, renal disease and diabetes, according to research published in the July issue of British Journal of Dermatology.
› Verified 4 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to distribute its HearTwave II System and proprietary Microvolt T-Wave Alternans (MTWA) software and Micro-V Alternans Sensors in Singapore upon regulatory approval.
Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd have developed a new treatment for cancer which rather than attacking tumours directly, prevents the growth of new blood vessels in tumours, starving them of oxygen and nutrients, thereby preventing their growth.
There is currently no cure for liver cirrhosis and a patient's only hope of survival is to receive a liver transplant.
Children with serious skin conditions feel their quality of life is impaired to the same extent as those with chronic illnesses such as epilepsy, renal disease and diabetes, according to research published in the July issue of British Journal of Dermatology.
› Verified 4 days ago
| Entity Name | The Gettysburg Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366472706 PECOS PAC ID: 2769373331 Enrollment ID: O20040323000809 |
News Archive
Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to distribute its HearTwave II System and proprietary Microvolt T-Wave Alternans (MTWA) software and Micro-V Alternans Sensors in Singapore upon regulatory approval.
Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd have developed a new treatment for cancer which rather than attacking tumours directly, prevents the growth of new blood vessels in tumours, starving them of oxygen and nutrients, thereby preventing their growth.
There is currently no cure for liver cirrhosis and a patient's only hope of survival is to receive a liver transplant.
Children with serious skin conditions feel their quality of life is impaired to the same extent as those with chronic illnesses such as epilepsy, renal disease and diabetes, according to research published in the July issue of British Journal of Dermatology.
› Verified 4 days ago
| Entity Name | North American Partners In Anesthesia, Pennsylvania , Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639137854 PECOS PAC ID: 7517960834 Enrollment ID: O20060807000040 |
News Archive
Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to distribute its HearTwave II System and proprietary Microvolt T-Wave Alternans (MTWA) software and Micro-V Alternans Sensors in Singapore upon regulatory approval.
Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd have developed a new treatment for cancer which rather than attacking tumours directly, prevents the growth of new blood vessels in tumours, starving them of oxygen and nutrients, thereby preventing their growth.
There is currently no cure for liver cirrhosis and a patient's only hope of survival is to receive a liver transplant.
Children with serious skin conditions feel their quality of life is impaired to the same extent as those with chronic illnesses such as epilepsy, renal disease and diabetes, according to research published in the July issue of British Journal of Dermatology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary M Monser, CRNA 785 5th Ave Ste 3, Chambersburg, PA 17201-4232 Ph: (717) 263-9555 | Mary M Monser, CRNA 112 N 7th St, Chambersburg, PA 17201-1720 Ph: (717) 267-7164 |
News Archive
Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to distribute its HearTwave II System and proprietary Microvolt T-Wave Alternans (MTWA) software and Micro-V Alternans Sensors in Singapore upon regulatory approval.
Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd have developed a new treatment for cancer which rather than attacking tumours directly, prevents the growth of new blood vessels in tumours, starving them of oxygen and nutrients, thereby preventing their growth.
There is currently no cure for liver cirrhosis and a patient's only hope of survival is to receive a liver transplant.
Children with serious skin conditions feel their quality of life is impaired to the same extent as those with chronic illnesses such as epilepsy, renal disease and diabetes, according to research published in the July issue of British Journal of Dermatology.
› Verified 4 days ago
William Bricker, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-7164 Fax: 717-267-7414 | |
Frieda Hildenbrand, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-3000 | |
Kaitlin Ganoe, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-7164 | |
Ms. Cheryl L. Baluh, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 112 N. Seventh Street, Chambersburg, PA 17201 Phone: 717-267-3000 Fax: 717-267-7414 | |
Priscilla Lathrop Young, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-3000 Fax: 717-267-7414 | |
Emily Renee Mellott, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-7164 Fax: 717-267-7414 | |
Carrie A Haggerty, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 835 5th Ave, Wellspan Anesthesiology, Chambersburg, PA 17201 Phone: 717-217-4312 |